1. Departamento de Hematologia, Hospital Universitari i Politècnic La Fe, Valencia, Spain;
2. Department of Medicine, University of Valencia, Valencia, Spain;
3. Centro de Investigación Biomédica en Red de Cáncer, Instituto Carlos III, Madrid, Spain;
4. Hôpital Saint-Louis, Assistance Publique Hôpitaux de Paris, Paris, France;
5. Department of Hematology, Université Paris Diderot, Paris, France;
6. Memorial Sloan Kettering Cancer Center, New York, NY;
7. Seattle Cancer Care Alliance, Seattle, WA;
8. Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands;
9. National Hospital Organization Nagoya Medical Center, Nagoya, Japan;
10. Department of Haematology, University Hospital Mannheim, University of Heidelberg, Mannheim, Germany;
11. Department of Internal Medicine III, Ulm University Hospital, Ulm, Germany;
12. Department of Haematology, Glasgow University, Glasgow, United Kingdom;
13. State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China;
14. Department of Hematology, Christian Medical College, Vellore, India;
15. Royal Prince Alfred Hospital, Camperdown, NSW, Australia;
16. Hematology Division and
17. Clinical Oncology Division, Department of Internal Medicine, University of Sao Paulo, Ribeirao Preto, Brazil;
18. Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX;
19. Hematology, Campus Bio-Medico University, Rome, Italy;
20. Medical Clinic and Polyclinic I, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany;
21. Centre for Clinical Haematology, Department of Haematology, Nottingham University Hospital, Nottingham, United Kingdom; and
22. Department of Biomedicine and Prevention, Tor Vergata University of Rome, Rome, Italy